4Gajra A, Newman N, Gamble GP, et al. Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer. J Clin Oncol, 2003, 21:1029-1034.
5Okamoto K, Sawai K, Minato H, et al. Number and anatomical extent of lymph node metastases in gastric cancer: analysis using intra-lymph node injection of activated carbon particles ( CH40 ). Jpn J Clin Oncol, 1999, 29:74-77.
6Naruke T, Suemasu K, Ishlkawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg, 1978, 76:832-839.
7Stella B, Arpicco S, Peracchia MT, et al. Design of folic acidconjugated nanoparticles for drug targeting. J Phann Sci, 2000, 89 : 1452-1464.
8Watanahe A, Koyanagi T, Ohsawa H, et al. Systematic node dissection by VATS is not inferior to that through an open thoracotomy: a comparative clinicopathologic retrospective study. Surgery, 2005, 138:510-517.
9Ludwig MS, Goodman M, Miller DL, et al. Postoperative survival and the number of lymph nodes sampled during resection of node-negative non-small cell lung cancer. Chest, 2005, 128:1545-1550.
